Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (20%) |
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRIDGES, DONAVAN LEE | 1 | — | — |
| KIM, YOUNG J | 1 | 64.8% | +18.0% |
| LEE, JIA-HAI | 1 | 49.8% | +48.0% |
| JOHANNSEN, DIANA B | 1 | 53.3% | +42.5% |
| HA, JULIE | 1 | 75.6% | +44.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704678 | JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT | KIM, YOUNG J | — |
| 18016601 | PROGNOSTIC BIOMARKERS FOR CANCER | JOHANNSEN, DIANA B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704678 | JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT | KIM, YOUNG J | — |
| 18545392 | NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS | LEE, JIA-HAI | — |
| 18016601 | PROGNOSTIC BIOMARKERS FOR CANCER | JOHANNSEN, DIANA B | — |
| 17633201 | STEREOSELECTIVE PH RESPONSIVE PEPTIDE DENDRIMERS FOR NUCLEIC ACID TRANSFECTION | HA, JULIE | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| 1682 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18705292 | MICROFLUIDIC CELL CULTURING DEVICE | BRIDGES, DONAVAN LEE | — | §103 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18704678 | JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT | KIM, YOUNG J | — | §101§102§103§112 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18545392 | NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS | LEE, JIA-HAI | 1658 | §102§103§112DP | Final Rejection | — | Pending | Dec 19, 2023 |
| 18016601 | PROGNOSTIC BIOMARKERS FOR CANCER | JOHANNSEN, DIANA B | 1682 | §101 | Final Rejection | — | Pending | Jan 17, 2023 |
| 17633201 | STEREOSELECTIVE PH RESPONSIVE PEPTIDE DENDRIMERS FOR NUCLEIC ACID TRANSFECTION | HA, JULIE | 1654 | §112 | Final Rejection | — | Pending | Feb 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial